MetLife Investment Management’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4M Buy
140,405
+29,737
+27% +$640K 0.02% 768
2026
Q1
$1.27M Buy
110,668
+613
+0.6% +$8.64K 0.01% 1289
2025
Q4
$1.58M Sell
110,055
-3,296
-3% -$57K 0.01% 1196
2025
Q3
$2.15M Buy
113,351
+3,785
+3% +$62.4K 0.01% 1054
2025
Q2
$2.35M Sell
109,566
-9,825
-8% -$146K 0.01% 929
2025
Q1
$1.57M Buy
119,391
+358
+0.3% +$5.32K 0.01% 1151
2024
Q4
$1.6M Buy
119,033
+6,553
+6% +$106K 0.01% 1176
2024
Q3
$2.39M Hold
112,480
– – 0.01% 925
2024
Q2
$1.78M Buy
112,480
+30,264
+37% +$556K 0.01% 1030
2024
Q1
$1.22M Hold
82,216
– – 0.01% 1188
2023
Q4
$752K Hold
82,216
– – 0.01% 1454
2023
Q3
$458K Hold
82,216
– – ﹤0.01% 1692
2023
Q2
$663K Buy
82,216
+16,471
+25% +$121K ﹤0.01% 1507
2023
Q1
$430K Buy
65,745
+17,310
+36% +$70.7K ﹤0.01% 1734
2022
Q4
$119K Sell
48,435
-16,948
-26% -$53K ﹤0.01% 2510
2022
Q3
$326K Hold
65,383
– – ﹤0.01% 1940
2022
Q2
$278K Buy
+65,383
New +$416K ﹤0.01% 2071

Other funds holding OSCR

MetLife Investment Management's OSCR Position: Q2 2026 in Review

MetLife Investment Management increased its Oscar Health (OSCR) stake by 27% in Q2 2026, buying an estimated $640K and bringing the position to 140,405 shares worth $4M. The position accounts for 0.02% of the portfolio, ranked #768.

MetLife Investment Management first reported a position in OSCR in Q2 2022 and has held it in 17 quarters since. 404 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • MetLife Investment Management held 140,405 shares of Oscar Health worth $4M as of Q2 2026.
  • MetLife Investment Management bought 29,737 Oscar Health shares in Q2 2026, an estimated $640K.
  • Oscar Health made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #768 holding.
  • MetLife Investment Management first reported a position in Oscar Health in Q2 2022 and has held it in 17 quarters since.
  • 404 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.